Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127372391 | 12737239 | 1 | I | 20160830 | 20160912 | 20160912 | EXP | US-ELI_LILLY_AND_COMPANY-US201608014468 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127372391 | 12737239 | 1 | PS | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | U | 21411 | 10 | MG | CAPSULE | QD | ||||
| 127372391 | 12737239 | 2 | SS | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | U | C158122C | 21411 | 10 | MG | CAPSULE | QD | |||
| 127372391 | 12737239 | 3 | C | DEEPLIN | 2 | Unknown | 60 MG, UNKNOWN | U | 0 | 60 | MG | ||||||||
| 127372391 | 12737239 | 4 | C | DICLOFENAC | DICLOFENAC | 1 | Unknown | 75 MG, UNKNOWN | U | 0 | 75 | MG | |||||||
| 127372391 | 12737239 | 5 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 20 MG, TID | U | 0 | 20 | MG | TID | ||||||
| 127372391 | 12737239 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 20 MG, QOD | U | 0 | 20 | MG | QOD | ||||||
| 127372391 | 12737239 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, UNKNOWN | U | 0 | 500 | MG | |||||||
| 127372391 | 12737239 | 8 | C | FUROSEMIDE /00032602/ | FUROSEMIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 127372391 | 12737239 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 1 MG, BID | U | 0 | 1 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127372391 | 12737239 | 1 | Attention deficit/hyperactivity disorder |
| 127372391 | 12737239 | 3 | Product used for unknown indication |
| 127372391 | 12737239 | 4 | Product used for unknown indication |
| 127372391 | 12737239 | 5 | Product used for unknown indication |
| 127372391 | 12737239 | 6 | Product used for unknown indication |
| 127372391 | 12737239 | 7 | Diabetes mellitus |
| 127372391 | 12737239 | 8 | Product used for unknown indication |
| 127372391 | 12737239 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127372391 | 12737239 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127372391 | 12737239 | Anger | |
| 127372391 | 12737239 | Drug dose omission | |
| 127372391 | 12737239 | Stress | |
| 127372391 | 12737239 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127372391 | 12737239 | 1 | 2015 | 0 |